Chalasani Venu, Chin Joseph L, Izawa Jonathan I
Departments of Surgery & Oncology, Divisions of Urology & Surgical Oncology, London Health Sciences Centre-Victoria Hospital, London, ON.
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S193-8. doi: 10.5489/cuaj.1195.
Bladder cancer can be classified histologically as urothelial or non-urothelial. Urothelial cancer has a propensity for divergent differentiation, which has increasingly been recognized in recent years due to heightened awareness and improved immunohistochemistry techniques. Furthermore, the recent World Health Organization classification of urothelial cancers improved clarity on this issue, with its listing of 13 histologic variants of urothelial cancer. The divergent differentiation patterns include, amongst others, squamous, glandular, micropapillary, nested, lymphepithelioma-like, plasmacytoid and sarcomatoid variants of urothelial cancer. Attempts to quantify the amount of divergent differentiation present, such as using the nonconventional differentiation number, have been made recently, which will improve the ability to compare publications from different centres. Genetic-based studies have indicated that the histologic variants of urothelial cancer arise from a common clonal precursor. Mostly, the current evidence suggests that urothelial cancer with divergent differentiation has a worse prognosis when compared with pure urothelial cancer. This article will review the current literature on variant histologies of urothelial cancer, and well as new developments in pure squamous cell carcinoma, small cell carcinoma and adenocarcinoma of the bladder.
膀胱癌在组织学上可分为尿路上皮癌或非尿路上皮癌。尿路上皮癌有分化异向的倾向,近年来由于认识的提高和免疫组化技术的改进,这一倾向越来越受到认可。此外,世界卫生组织最近对尿路上皮癌的分类提高了对此问题的清晰度,列出了13种尿路上皮癌的组织学变体。分化异向模式包括尿路上皮癌的鳞状、腺性、微乳头、巢状、淋巴上皮瘤样、浆细胞样和肉瘤样变体等。最近有人尝试量化存在的分化异向程度,如使用非常规分化数,这将提高比较不同中心发表文章的能力。基于基因的研究表明,尿路上皮癌的组织学变体起源于共同的克隆前体。目前的证据大多表明,与单纯尿路上皮癌相比,具有分化异向的尿路上皮癌预后较差。本文将综述目前关于尿路上皮癌变体组织学的文献,以及膀胱纯鳞状细胞癌、小细胞癌和腺癌的新进展。